INVENTIVA (EPA:IVA) | WebDisclosure

Basculer en Français

9865	Companies
198267	Keywords
129311	Articles
105440	Press releases

Home
Companies
INVENTIVA

BRIEF

published on 10/01/2025 at 08:35, 4 months 13 days ago

Andrew Obenshain Appointed as CEO of Inventiva

Leadership Transition Drug Development Inventiva MASH Treatment Andrew Obenshain
PRESS RELEASE

published on 10/01/2025 at 08:30, 4 months 13 days ago

Inventiva annonce la nomination d’Andrew Obenshain au poste de Directeur Général
Inventiva annonce la nomination d'Andrew Obenshain au poste de Directeur Général, marquant une transition de leadership stratégique pour la société biopharmaceutique spécialisée dans le traitement de la MASH

Directeur Général Transition De Leadership Inventiva MASH Andrew Obenshain
PRESS RELEASE

published on 10/01/2025 at 08:30, 4 months 13 days ago

Inventiva Appoints Andrew Obenshain as Chief Executive Officer
Inventiva appoints Andrew Obenshain as Chief Executive Officer, succeeding Frédéric Cren, to lead company's growth and prepare for potential commercialization in the United States

Chief Executive Officer Inventiva MASH Frédéric Cren Andrew Obenshain
PRESS RELEASE

published on 09/29/2025 at 13:55, 4 months 15 days ago

RFS
BRIEF

published on 09/24/2025 at 22:05, 4 months 20 days ago

Inventiva organizes an event for analysts and investors

Event Phase 3 Inventiva MASH Lanifibranor
BRIEF

published on 09/24/2025 at 22:05, 4 months 20 days ago

Inventiva organise un événement pour analystes et investisseurs

Phase 3 Événement Inventiva MASH Lanifibranor
PRESS RELEASE

published on 09/24/2025 at 22:00, 4 months 20 days ago

Inventiva to Host Analyst and Investor Event on October 8, 2025
Inventiva to host analyst and investor event on October 8, 2025 featuring updates on lanifibranor and key MASH trends. Renowned experts to share insights on MASH landscape

Inventiva Lanifibranor Analyst Event MASH Trends Expert Insights
PRESS RELEASE

published on 09/24/2025 at 22:00, 4 months 20 days ago

Inventiva organise un événement analystes et investisseurs le 8 octobre 2025
Inventiva organisera un événement pour analystes et investisseurs le 8 octobre 2025 à New York, présentant lanifibranor, traitement de la stéatohépatite (MASH)

Événement Inventiva MASH Analystes Lanifibranor
BRIEF

published on 08/25/2025 at 10:02, 5 months 20 days ago

JP Morgan crosses threshold at Inventiva

Voting Rights Actions Threshold Crossing JP Morgan Inventiva
BRIEF

published on 08/25/2025 at 10:02, 5 months 20 days ago

Franchissement de seuil par J.P. Morgan chez Inventiva

Droits De Vote Franchissement De Seuil Actions Inventiva J.P. Morgan

Accesswire

Published on 02/14/2026 at 01:00, 1 day 2 hours ago

Orogen Royalties Announces Annual Equity Compensation Grant
Published on 02/13/2026 at 22:30, 1 day 4 hours ago

Norse Gold Corp. Announces New Director
Published on 02/13/2026 at 22:15, 1 day 4 hours ago

Storm Completes Sale of Miminiska Project for $5.8M and Outlines Plans for 2026
Published on 02/13/2026 at 17:45, 1 day 9 hours ago

Eldorado Gold Closes $2.4 Million Strategic Investment in Gemdale Gold
Published on 02/13/2026 at 14:35, 1 day 12 hours ago

Datametrex Received $500,000 Purchase Order For Data Centre Solutions

View all ACCESSWIRE

EQS Group

Published on 02/14/2026 at 16:30, 10 hours 29 minutes ago

Milano Cortina 2026 Licensed Candies Released Globally
Published on 02/14/2026 at 06:05, 20 hours 54 minutes ago

The 139th Canton Fair Promotion Conferences to Be Held in Germany and Morocco, Highlighting Targeted Industry Opportunities
Published on 02/13/2026 at 19:20, 1 day 7 hours ago

Retail offering successfully completed and update on Euronext Growth Oslo listing
Published on 02/13/2026 at 19:01, 1 day 7 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/13/2026 at 18:20, 1 day 8 hours ago

GLOBAL TECHNOLOGY LEADERS LAUNCH TRUSTED TECH ALLIANCE

Les Echos

Published on 02/14/2026 at 07:00, 20 hours ago

Groupe DLSI - Chiffre d'affaires 2025
Published on 02/13/2026 at 18:05, 1 day 8 hours ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/01/2026
Published on 02/13/2026 at 18:05, 1 day 8 hours ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/01/2026
Published on 02/13/2026 at 17:50, 1 day 9 hours ago

Number of shares and voting rights - January 2026 (In French only)
Published on 02/13/2026 at 17:50, 1 day 9 hours ago

Nombre total d'actions et droits de vote - janvier 2026

View all LES ECHOS COMFI WIRE